NASDAQ : XAIR
Beyond Air, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 2.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.27M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.21M |
| Enterprise Value | 15.99M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 984,407 |
| Shares Outstanding | 984,407 |
| Shares Change (YoY) | +162.07% |
| Shares Change (QoQ) | +8.57% |
| Owned by Insiders (%) | 20.46% |
| Owned by Institutions (%) | 7.97% |
| Float | 782,964 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.29 |
| Forward PS | 0.16 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.31 |
| Quick Ratio | 1.60 |
| Debt / Equity | 8.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.29 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -519.51% |
| Return on Assets (ROA) | -57.45% |
| Return on Invested Capital (ROIC) | -72.22% |
| Return on Capital Employed (ROCE) | -107.91% |
| Weighted Average Cost of Capital (WACC) | 14.11% |
| Revenue Per Employee | $142,352 |
| Profits Per Employee | -$620,241 |
| Employee Count | 54 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 3.85 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -94.54% |
| 50-Day Moving Average | 3.04 |
| 200-Day Moving Average | 10.47 |
| Relative Strength Index (RSI) | 39.70 |
| Average Volume (20 Days) | 30,746 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 59,684 |
| Short Previous Month | 62,761 |
| Short % of Shares Out | 6.06% |
| Short % of Float | 7.62% |
| Short Ratio (days to cover) | 0.74 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 7.69M |
| Gross Profit | 321,000 |
| Operating Income | -28.04M |
| Pretax Income | -34.41M |
| Net Income | -33.49M |
| EBITDA | -24.80M |
| EBIT | -28.04M |
| Loss Per Share | -$62.88 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.81M |
| Total Debt | 23.60M |
| Net Cash | -13.79M |
| Net Cash Per Share | -$14.00 |
| Equity (Book Value) | 2.84M |
| Book Value Per Share | 2.69 |
| Working Capital | 15.94M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -18.56M |
| Capital Expenditures | -1.04M |
| Depreciation & Amortization | 3.24M |
| Net Borrowing | 12.00M |
| Free Cash Flow | -19.60M |
| FCF Per Share | -$19.91 |
Margins
| Measure | Value |
|---|
| Gross Margin | 4.18% |
| Operating Margin | -364.76% |
| Pretax Margin | -447.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -162.07% |
| Shareholder Yield | -162.07% |
| Earnings Yield | -2,806.92% |
| FCF Yield | -888.81% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $20.00 |
| Price Target Difference | 792.86% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 58.45% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 13, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -15.72 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |